This is a modal window.
Syncvision and iFR Co-Registration (part 1)
Dr Justin Davies reviews the current state of iFR and iFR-Co-registration at EuroPCR 2018
Learning objectives:-
- Understand the limitations of FFR in assessing serial lesions
- Understand how iFR...
Dr Justin Davies reviews the current state of iFR and iFR-Co-registration at EuroPCR 2018
Learning objectives:-
- Understand the limitations of FFR in assessing serial lesions
- Understand how iFR overcomes the limitations of serial lesion assessment
- See how iFR co-registration can help localise physiological lesions on the coronary angiogram
- Understand the importance of differentiation between diffuse and focal disese
- Using iFR Co-registration to plan revascularisation decision-making
Target audience:-
- Coronary interventionist
- Physiologists
- Healthcare professionals
Simple Education, is a leading provider of coronary physiology and intracoronary imaging courses to aid treatment of complex coronary artery disease.
Speakers
Justin Davies
Speaker
Dr Justin Davies is a honorary interventional cardiologist at Hammersmith Hospital, Imperial... Dr Justin Davies is a honorary interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents, he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).
